Insider Transactions
| Date | Name | Title | Type | Shares Traded | Price Range |
|---|---|---|---|---|---|
| Jan 16, 2020 |
EVP, COO & CCO
|
EVP, COO & CCO | Open market or private sale of non-derivative or derivative security | 11,381 | $3.37 |
| Jan 16, 2020 |
Director, CEO & President
|
Director, CEO & President | Open market or private sale of non-derivative or derivative security | 3,753 | $3.37 |
| Nov 08, 2019 |
Chief Medical Officer
|
Chief Medical Officer | Other acquisition or disposition | -- | -- |
| Nov 06, 2019 |
Chief Medical Officer
|
Chief Medical Officer | Open market or private sale of non-derivative or derivative security | 6,963 | $8.16 |
| Aug 12, 2019 |
Chief Legal Officer
|
Chief Legal Officer | Open market or private sale of non-derivative or derivative security | 294 | $7.77 |
| Aug 12, 2019 |
Chief Legal Officer
|
Chief Legal Officer | Other acquisition or disposition | -- | -- |
| Jun 21, 2019 |
Chief Medical Officer
|
Chief Medical Officer | Other acquisition or disposition | -- | -- |
| Jun 21, 2019 |
Chief Medical Officer
|
Chief Medical Officer | Initial Statement of Beneficial Ownership of Securities | -- | -- |
| Jun 21, 2019 |
Chief Medical Officer
|
Chief Medical Officer | Initial Statement of Beneficial Ownership of Securities | -- | -- |
| Jun 21, 2019 |
Chief Medical Officer
|
Chief Medical Officer | Initial Statement of Beneficial Ownership of Securities | -- | -- |
| Jun 21, 2019 |
Chief Medical Officer
|
Chief Medical Officer | Initial Statement of Beneficial Ownership of Securities | -- | -- |
| Jun 21, 2019 |
Chief Legal Officer
|
Chief Legal Officer | Other acquisition or disposition | -- | -- |
| Jun 20, 2019 |
Director
|
Director | Open market or private sale of non-derivative or derivative security | 1,667 | $8.50 |
| Jun 20, 2019 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,000 | -- |
| Jun 20, 2019 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- |
| Jun 20, 2019 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,000 | -- |
| Jun 20, 2019 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- |
| Jun 20, 2019 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,000 | -- |
| Jun 20, 2019 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- |
| Jun 20, 2019 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,000 | -- |
| Jun 20, 2019 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- |
| Jun 20, 2019 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,000 | -- |
| Jun 20, 2019 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- |
| Jun 20, 2019 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,000 | -- |
| Jun 20, 2019 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.